GLP-1 medication
The retail giant's platform will now include obesity and weight management support from Wheel, Curai Health, Aaptiv, Berry Street and MyCare by Twin Health.
The company will use the funds to expand its agentic AI platform and fund new models for employers, including access to GLP-1 medications.
The program connects self-pay patients with clinicians to access GLP-1s, including Wegovy, starting at $149 per month, with no subscription fee.
The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.
Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic disease risk and aging.
The alliance brings both companies' offerings under a single operating platform.